What the company does
Sanigen provides food-safety testing and sterilisation products that help food manufacturers detect harmful bacteria and viruses in their products.
Its customers are domestic and international food producers that use its diagnostic kits, genomic-analysis services, and sterilisation solutions to manage contamination risks. Listed on KOSDAQ, Korea's tech and small-cap board, the company supplies a full-cycle portfolio spanning molecular diagnostic products, laboratory consumables, and microbial-control agents under its own brands.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$14.6M
- FY2024US$11.2M
- FY2025US$11.1M
Operating profit
- FY2023−US$4.7M
- FY2024−US$4.3M
- FY2025−US$3.2M
Net income
- FY2023−US$6.7M
- FY2024−US$4.8M
- FY2025−US$4.2M
Key ratios (FY2025)
Why it matters · Context, not a recommendation
Sanigen absorbed a Korean special-purpose acquisition company through a merger, which was the mechanism by which it gained its current listed status on KOSDAQ.
Filings
All disclosures · English when translatedPrice charts coming soon
Interactive price history isn't here yet. Would you use it?